ISRCTN69078742已完成未知
MRSA eradication in Cystic Fibrosis: treatment protocol and impact on lung function decline and lung clearance index
niversity Hospital Brussels (Universitair Ziekenhuis Brussel [UZ Brussel]) (Belgium)0 个研究点目标入组 11 人开始时间: 2013年4月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 11
研究概览
简要总结
2013 results in https://pubmed.ncbi.nlm.nih.gov/23706641/ (added 13/08/2020)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Cystic fibrosis (CF) patients (diagnosis confirmed by sweat test)
- •2. Age greater than 6 years - 60 years, either sex
- •3. Newly acquired MRSA
排除标准
- •1. Lung transplantation
- •2. Pregnancy
研究者
相似试验
已完成
2 期
Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)Cystic FibrosisNCT01594827Johns Hopkins University29
已完成
不适用
Initial and Chronic Methicillin Resistant Staphylococcus Aureus (MRSA) Infection in Cystic Fibrosis (CF)Methicillin-Resistant Staphylococcus AureusCystic FibrosisNCT02684422University of North Carolina, Chapel Hill48
终止
2 期
Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)Methicillin-resistant Staphylococcus AureusCystic FibrosisNCT01349192University of North Carolina, Chapel Hill47
已完成
不适用
Real-life Follow-up of Cystic Fibrosis Patients Treated With Ivacaftor+Lumacaftor (Orkambi*)Cystic FibrosisNCT03475381Assistance Publique - Hôpitaux de Paris852
已完成
3 期
Trial of Aeroquin Versus Tobramycin Inhalation Solution (TIS) in Cystic Fibrosis (CF) PatientsCystic FibrosisNCT01270347Amgen282